Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications

Globalization and Health

Alessandra Ferrario¹  Erofile Gripiotis¹  Larbi Lamri² 

[1] London School of Economics and Political Science, Houghton Street, London WC2A 2AE, UK;University of Algiers, Rue Didouche Mourad, Algiers, Algeria

关键词: Diabetes management;    Prevalence;    Algeria;    Costs;    Diabetes;   

Others  :  803896
DOI  :  10.1186/1744-8603-10-11

 received in 2013-01-25, accepted in 2014-01-27,  发布年份 2014

【 摘 要 】

Background

Diabetes has become an increasingly prevalent and severe public health issue in Algeria. This article investigates the prevalence, the cost and the management of this disease. Its first objective is to better understand the burden (both from an epidemiological and economic perspective) and management of diabetes. The second objective is to understand the health policy strategy adopted by Algeria in order to respond to the disease.

Methods

We conducted a literature review of prevalence, costs, management and outcomes of diabetes and its complications. This was complemented by data compilations and results of expert consultations.

Results

The epidemiology of diabetes is continually evolving and is becoming more problematic. The national evidence suggests that the prevalence of diabetes in Algeria has increased from 6.8% in 1990 to 12.29% in 2005, but is quite higher among certain groups and areas of the country. This disease affects all population groups, especially 35–70 year olds, who constitute a large segment of the working population. There are very few estimates of the cost of diabetes. These include a 1998 study on the total cost of type 1 diabetes (USD 11.6 million, which, inflated to 2013 value, totals to USD 16.6 million), a study on the cost of complications in 2010 (at 2013 value, ranging from USD 141 for first-year treatment of peripheral vascular disease to USD 30,441 for first-year cost of renal transplantation) and the 2013 IDF estimates of total cost of type 1 and type 2 diabetes (USD 513 million).

Conclusions

As the prevalence of diabetes continues to increase, the financial burden will increasingly weigh heavily on social security resources and the government budget. Future priorities must focus on empowering general practitioners in treating type 2 diabetes, improving screening of diabetes and its complications, tackling the growing obesity epidemic, strengthening health information systems and implementing the national diabetes prevention and control plan.

【 授权许可】

   
2014 Lamri et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]World Health Organization: Countries: Algeria. 2012. Online Available: http://www.who.int/countries/dza/en webcite, [Accessed: 19-Dec-2013]
• [2]Boudiba A, Mimouni-Zerguini S: Améliorer la prévention et les soins du diabète en Algérie. Diabetes Voice 2008, 53(2):19-21.
• [3]Malek R: Épidémiologie du diabète en Algérie: revue des données, analyse et perspectives. Médecine Mal. Métaboliques 2011, 5(4):29-33.
• [4]Central Intelligence Agency: The world factbook. Algeria; [https://www.cia.gov/library/publications/the-world-factbook/geos/ag.html webcite], Accessed: 19-Dec-2013
• [5]World Health Organization: World health statistics. 2013. [Online]. Available: http://www.who.int/gho/publications/world_health_statistics/EN_WHS2013_Part3.pdf webcite, Accessed: 19-Dec-2013
• [6]World Health Organization: Global health expenditure database. 2013. [Online]. Available: http://apps.who.int/nha/database/StandardReport.aspx?ID=REP_WEB_MINI_TEMPLATE_WEB_VERSION&COUNTRYKEY=84519 webcite, Accessed: 19-Dec-2013
• [7]Lamri L: Le système de sécurité sociale en Algérie: Approche économique. Algiers: Office des Publications Universitaires; 2004.
• [8]United States Department of Labor: Inflation calculator. Bureau of Labor Statistics[Online]. Available: http://www.bls.gov/data/inflation_calculator.htm webcite, Accessed: 19-Dec-2013
• [9]Institut National de Santé Publique: Enquête Nationale de Santé 1990. Algiers; 1992.
• [10]Bureau de l'Organisation mondiale de la Santé: Mesure des facteurs de risque des maladies non transmissibles dans 2 villages pilotes en Algérie-Approche STEPWise. Algiers; 2005.
• [11]Ministère de la Santé, de la Population et de la Réforme Hospitalière/UNICEF/Office National des Statistiques: Enquête Nationale à Indicateurs Multiples (MICS 3) - Rapport final. Algiers: UNICEF; 2008.
• [12]Institut National de Santé Publique - Programme INCO-MED: Etude TAHINA - La transition épidémiologique et son impact sur la santé dans les pays nord africains. Algiers; 2007.
• [13]Belhadj M, Malek R, Boudiba A, Lezzar E, Roula D, Sekkal F, Zinai S: DiabCare Algérie. Médecine Mal Métaboliques 2011, 5(4):24-28.
• [14]Lamri L, Atek A: Priorités de santé en Algérie - Rapport pour la Banque Mondiale. Algiers: Institut National de Santé Publique; 1998.
• [15]Hnoosh A, Vega-Hernández G, Jugrin A, Todorova L: PDB47 Direct medical management costs of diabetes-related complications in Algeria. Value Health 2012, 15(4):A179.
• [16]Zaoui S, Biémont C, Meguenni K: Approche épidémiologique du diabète en milieu urbain et rural. Cah D’Etudes Rech Francoph 2007, 17(1):15-21.
• [17]Malek R, Belateche F, Laouamri S, Hamdi-Cherif M, Touabti A, Bendib W, Nechadi A, Mekideche FZ, Hanat S: Prevalence of type 2 diabetes mellitus and glucose intolerance in the Setif area (Algeria). Diabetes Metab 2001, 27(2 Pt 1):164-171.
• [18]Abrouk S: Enquête épidémiologique transversale descriptive à recrutement prospectif. Algiers: Institut National de Santé Publique; 2010.
• [19]Belhadj M, Ousidhoum M, Midoune N, Cherrak A, Aribi S, Bachaoui M, Ayad F: The prevalence of Type 2 diabetes mellitus in Touaregs of South Algeria. J Diabetes Metab 2003, 29:298-302.
• [20]Bouhabel A, Laib Z, Hannache K, Aberkane A: Renal replacement therapy by hemodialysis in constantine (Algeria). Nephrol Ther 2013, 10(1):39-43.
• [21]Barkat A, Kherroubi R, Hartani D: Profil épidémiologique de la rétinopathie diabétique dans la wilaya d’Alger en 2009 chez les patients diabétiques adultes connus et traités; Clinique ophtalmologie. Algiers: Centre Hospitalier Universitaire (CHU) Mustapha Bacha; 2010.
• [22]Latifa BH, Kaouel M: Cardiovascular risk factors in Tlemcen (Algeria). Santé Montrouge Fr 2007, 17(3):153-158.
• [23]Belmokhtar F, Belmokhtar R, Charef M: Risk factors associated with type 2 diabetes mellitus in west region of Algeria, Maghnia. J Diabetes Metab 2011, 2:5.
• [24]Dali-Sahi M, Benmansour D, Aouar A, Karam N: Type 2 dans des populations endogames de l’ouest algérien. Leban Sci J 2012, 13(2):17.
• [25]Chentli F, Azzoug S, Amani MEA, Elgradechi A: Diabetes mellitus and Ramadan in Algeria. Indian J Endocrinol Metab 2013, 17(1):S295-298.
• [26]International Diabetes Federation: IDF diabetes atlas. 6th edition. 2013. [Online]. Available: http://www.idf.org/atlasmap/atlasmap webcite, Accessed: 19-Dec-2013
• [27]Mimouni-Zerguini S, Smail M, Boudiba A, Derguini M: Diabète gestationnel: facteurs de risque, évolution et conséquences périnatales: expérience du CHU Mustapha Bacha, Alger (Algérie). Médecine Mal Métaboliques 2009, 3:6.
• [28]Office National des Statistiques: Recensement 2008 - Résultats préliminaires. Algiers; 2010.
• [29]Zhang P, Zhang X, Brown JB, Vistisen D, Sicree RA, Shaw J, Nichols GA: Economic impact of diabetes. 2010. [Online]. Available: http://www.idf.org/sites/default/files/Economic_impact_of_Diabetes.pdf webcite, Accessed: 19-Dec-2013
• [30]Sadek M: Algerian study finds blood relatives continue to marry at a high rate. Magharebia 2007. [Online]. Available: http://magharebia.com/en_GB/articles/awi/features/2007/11/14/feature-03 webcite, Accessed: 19-Dec-2013
• [31]Ministère de la Santé, de la Population et de la Réforme Hospitalière: Rapport du séminaire-atelier d’élaboration du programme national de lutte intégrée contre les maladies non transmissibles. 2003. [Online]. Available:http://www.1sante.com/news/stories.php?story=03/04/02/8923252 webcite, Accessed: 19-Dec-2013